ArticleDermatology and therapy2025

Long-Term Effectiveness, Safety, and Predictive Factors of Tralokinumab Response in Adolescents with Atopic Dermatitis: Insights from a Real-World Multicenter Cohort.

Pilar Villodre Lozano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.